Optimizing Delivery of Therapeutic Growth Factors for Bone and Cartilage Regeneration
Gels · 03.05.2023 · 9 (5) · 377
DOI: 10.3390/gels9050377 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Gels, online erschienen am 03.05.2023. Verfasst von Eri Takematsu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Stanford Medicine, Stanford, CA 94305, USA. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 141 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institute of Health, Japan Society for the Promotion of Science, NIH–NIA.
Abstract (Originalsprache)
Bone- and cartilage-related diseases, such as osteoporosis and osteoarthritis, affect millions of people worldwide, impairing their quality of life and increasing mortality. Osteoporosis significantly increases the bone fracture risk of the spine, hip, and wrist. For successful fracture treatment and to facilitate proper healing in the most complicated cases, one of the most promising methods is to deliver a therapeutic protein to accelerate bone regeneration. Similarly, in the setting of osteoarthritis, where degraded cartilage does not regenerate, therapeutic proteins hold great promise to promote new cartilage formation. For both osteoporosis and osteoarthritis treatments, targeted delivery of therapeutic growth factors, with the aid of hydrogels, to bone and cartilage is a key to advance the field of regenerative medicine. In this review article, we propose five important aspects of therapeutic growth factor delivery for bone and cartilage regeneration: (1) protection of protein growth factors from physical and enzymatic degradation, (2) targeted growth factor delivery, (3) controlling GF release kinetics, (4) long-term stability of regenerated tissues, and (5) osteoimmunomodulatory effects of therapeutic growth factors and carriers/scaffolds.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Surgery, Stanford Medicine, Stanford, CA 94305, USA.
- Blond McIndoe Laboratories, School of Biological Science, Faculty of Biology, Medicine and Health, University of Manchester, Manchester M13 9PR, UK.
- School of Medicine, University of California, San Francisco, CA 94143, USA.
- Department of Orthopaedic Surgery, University of California, Davis, CA 95817, USA.
- Institute for Stem Cell Biology and Regenerative Medicine, Stanford Medicine, Stanford, CA 94305, USA.
ORCID-Profile: Eri Takematsu, Holly Steininger, Thomas H Ambrosi
Förderung
- National Institute of Health
- Japan Society for the Promotion of Science
- NIH–NIA
Zitieren
APA
Takematsu, E., Murphy, M., Hou, S., Steininger, H., Alam, A., Ambrosi, T. H., & Chan, C. K. F. (2023). Optimizing Delivery of Therapeutic Growth Factors for Bone and Cartilage Regeneration. Gels, 9(5), 377. https://doi.org/10.3390/gels9050377
Vancouver
Takematsu E, Murphy M, Hou S, Steininger H, Alam A, Ambrosi TH, et al. Optimizing Delivery of Therapeutic Growth Factors for Bone and Cartilage Regeneration. Gels. 2023;9(5):377. doi:10.3390/gels9050377
BibTeX
@article{Takematsu2023,
author = {Takematsu, Eri and Murphy, Matthew and Hou, Sophia and Steininger, Holly and Alam, Alina and Ambrosi, Thomas H and Chan, Charles K F},
title = {Optimizing Delivery of Therapeutic Growth Factors for Bone and Cartilage Regeneration},
journal = {Gels},
year = {2023},
volume = {9},
number = {5},
pages = {377},
doi = {10.3390/gels9050377}
}
EUVIMED